Mahesh B Chandrasekharan

Has grant

Investigator

University of Utah School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Mahesh B Chandrasekharan is an Assistant Professor at the University of Utah School of Medicine, United States. His research focuses on the mechanisms of gene regulation, particularly in the context of histone modifications, DNA repair, and cellular reprogramming. He has published recent articles exploring topics such as ubiquitination dynamics and the roles of transcription factors in lineage specification.

Recent Grants

Grant: Close

A versatile pan-spike-in internal reference genome methodology for quantitative ChIP-seq normalization

Open Date: 2021-01-01

Close Date: 2022-12-31

Grant: Close

Structure, function and regulation of the H2B ubiquitin-conjugating complex

Open Date: 2018-05-01

Close Date: 2023-04-30

Grant: Close

Genome-wide occupancy and orientation mapping of nucleosomes asymmetrically modified at histone H3 lysine-4-a novel mark of active transcription

Open Date: 2017-04-19

Close Date: 2019-03-31

Articles (13)

Year:

2026

Year:

2026

Year:

2025

Year:

2024

The transition between pluripotent and tissue-specific states is a key aspect of development. Understanding the pathways driving these transitions will facilitate the engineering of properly differentiated cells for experimental and therapeutic uses. Here, we showed that during mesoderm differentiation, the transcription factor Oct1 activated developmental lineage–appropriate genes that were silent in pluripotent cells. Using mouse embryonic stem cells (ESCs) with an inducible knockout of Oct1, we showed that Oct1 deficiency resulted in poor induction of mesoderm-specific genes, leading to impaired mesodermal and terminal muscle differentiation. Oct1-deficient cells exhibited poor temporal coordination of the induction of lineage-specific genes and showed inappropriate developmental lineage branching, resulting in poorly differentiated cell states retaining epithelial characteristics. In ESCs, Oct1 localized with the pluripotency factor Oct4 at mesoderm-associated genes and remained bound to those loci during differentiation after the dissociation of Oct4. Binding events for Oct1 overlapped with those for the histone lysine demethylase Utx, and an interaction between Oct1 and Utx suggested that these two proteins cooperate to activate gene expression. The specificity of the ubiquitous Oct1 for the induction of mesodermal genes could be partially explained by the frequent coexistence of Smad and Oct binding sites at mesoderm-specific genes and the cooperative stimulation of mesodermal gene transcription by Oct1 and Smad3. Together, these results identify Oct1 as a key mediator of mesoderm lineage–specific gene induction.

Year:

2023

The conserved complex of the Rad6 E2 ubiquitin-conjugating enzyme and the Bre1 E3 ubiquitin ligase catalyzes histone H2B monoubiquitination (H2Bub1), which regulates chromatin dynamics during transcription and other nuclear processes. Here, we report a crystal structure of Rad6 and the non-RING domain N-terminal region of Bre1, which shows an asymmetric homodimer of Bre1 contacting a conserved loop on the Rad6 ‘backside’. This contact is distant from the Rad6 catalytic site and is the location of mutations that impair telomeric silencing in yeast. Mutational analyses validated the importance of this contact for the Rad6–Bre1 interaction, chromatin-binding dynamics, H2Bub1 formation and gene expression. Moreover, the non-RING N-terminal region of Bre1 is sufficient to confer nucleosome binding ability to Rad6 in vitro. Interestingly, Rad6 P43L protein, an interaction interface mutant and equivalent to a cancer mutation in the human homolog, bound Bre1 5-fold more tightly than native Rad6 in vitro, but showed reduced chromatin association of Bre1 and reduced levels of H2Bub1 in vivo. These surprising observations imply conformational transitions of the Rad6–Bre1 complex during its chromatin-associated functional cycle, and reveal the differential effects of specific disease-relevant mutations on the chromatin-bound and unbound states. Overall, our study provides structural insights into Rad6–Bre1 interaction through a novel interface that is important for their biochemical and biological responses.

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (9)

Lauren Woodward

Assistant Professor

Taylor University

UNITED STATES
View details

Hiroshi Handa

Tokyo Medical and Dental University

JAPAN
View details

Krzysztof Mrózek

The Ohio State University Comprehensive Cancer Center

UNITED STATES
View details

Eric Huang

University of Utah

UNITED STATES
View details

Dimitrios Papaioannou

Assistant Professor

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health

UNITED STATES
View details

Dean Tantin

Associate Professor

University of Utah School of Medicine

UNITED STATES
View details

Amog Prathap Urs

Research Scientist

Huntsman Cancer Institute

UNITED STATES
View details

Rémi Buisson

Associate Professor

University of California, Irvine

UNITED STATES
View details

Deedra Nicolet

Ohio State University

UNITED STATES
View details